期刊文献+

凋亡抑制蛋白Livin在宫颈癌及宫颈上皮内瘤变表达 被引量:3

Expression of Inhibitor of Apoptosis Protein,Livin in Cervical Carcinoma and Cervical Intraepithelia Neoplasia
原文传递
导出
摘要 [目的]探讨凋亡抑制蛋白Livin在宫颈上皮内瘤变(CIN)和宫颈癌中的表达及意义。[方法]采用免疫组织化学SP法检测81例宫颈癌、74例CIN和20例正常宫颈组织中Livin的表达情况。[结果]Livin在正常宫颈组织中不表达,在CIN和宫颈癌中表达上调,阳性率分别为31.08%(23/74)和67.90%(55/81)。Livin在CINⅢ组织中的阳性率高于CINⅠ~Ⅱ。Livin表达与肿瘤临床分期、分化程度及淋巴结转移有关(P<0.05),而与病理类型、肿块生长类型无相关性(P>0.05)。[结论]Livin过表达可能与CIN和宫颈癌的发生发展有关,提示肿瘤的恶性程度及不良预后。 [Purpose] To investigate the expression and significance of Livin in CIN and cervical carcinoma. [Methods] The expressions of Livin in 81 cases with cervical carcinoma,74 cases with CIN and 20 cases with normal cervix were detected by SP immunohistochemistry. [Results] Negative expression of Livin in normal cervix tissue,overexpression in CIN and in cervical carcinoma tissue were found,with positive rates 0,31.08%(23/74) and 67.90%(55/81),respectively. The positive rate in CINⅢ was higher than that in CINⅠ~Ⅱ.The expression of Livin in cervical carcinoma was related to clinical stages,degree of differentiation and lymph node metastasis (P 0.05),and it was not related to pathological type and tumor growth type (P0.05). [Conclusion] Over expression of Livin might play an important role in carcinogenesis of CIN and cervical carcinoma,and indicate poor prognosis.
出处 《肿瘤学杂志》 CAS 2010年第7期566-568,共3页 Journal of Chinese Oncology
基金 温州市科技局科研基金(Y20070126)
关键词 凋亡抑制蛋白 LIVIN 宫颈上皮内瘤变 宫颈肿瘤 inhibitor of apoptosis protein Livin cervical intraepithelia neoplasia cervical neoplasms
  • 相关文献

参考文献9

  • 1Lin JH, Deng G, Huang Q, et al. KIAP, a novel member of the inhibitor of apoptosis protein family [J]. Biochem Biophys Res Commun, 2000, 279(3): 820-831.
  • 2Kasof GM, Gomes BC. Livin, a novel inhibitor of apoptosis protein family member [J]. J Biol Chem, 2001, 276(5): 3238-3246.
  • 3Vucic D, Stennicke HR, Pisabarro MT, et al. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas [J]. Curr Biol, 2000, 10 (21): 1359- 1366.
  • 4Sanna MG, da Silva Correia J, Ducrey O, et al. IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition[J]. Mol Cell Biol, 2002, 22(6):1754-1766.
  • 5Frankin MC, Kadkhodayan S, Ackerly H, et al. Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP)[J]. Biochemistry,2003, 42 (27) : 8223-8231.
  • 6Yagihashi A, Asanuma K, Tsuji N, et al. Detection of antilivin antibody in gastrointestinal cancer patients [J].Clin Chem, 2003, 49(7): 1206-1208.
  • 7Crnkovic-Mertens I, Hoppe-Seyler F, Butz K. Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene [J]. Oncogene, 2003, 22(51): 8330-8336.
  • 8Tanabe H, Yagihashi A, Tsuji N, et al. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer[J]. Lung Cancer, 2004, 46(3):299-304.
  • 9Yagihashi A, Ohmura T, Asanuma K, et al. Detection of autoantibodies to survivin and livin in sera from patients with breast cancer [J]. Clin Chim Acta, 2005, 362(1-2): 125-130.

同被引文献23

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部